Product Details for: Lunsumio
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
1MG/ML
Single-Dose Vial
351(a)
Lunsumio
Rx
002
Injection
Intravenous
30MG/30ML (1MG/ML)
Single-Dose Vial
351(a)
Lunsumio
Rx
003
Injection
Subcutaneous
5MG/0.5ML
Single-Dose Vial
351(a)
Lunsumio Velo
Rx
004
Injection
Subcutaneous
45MG/ML
Single-Dose Vial
351(a)
Lunsumio Velo
Rx
Proper Name
mosunetuzumab-axgb
mosunetuzumab-axgb
BLA Number
761263
761263
Applicant
Genentech, Inc.
Genentech, Inc.
Original Approval Date
December 22, 2022
December 22, 2022
Date of First Licensure